Coegin Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '24 Sep 5, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	91	51	97	228	-
Market Cap Growth	-62.53%	-47.61%	-57.59%	-	-
Enterprise Value	72	44	92	196	-
Last Close Price	5.68	5.38	13.46	36.01	-
PE Ratio	-	-1.77	-2.62	-7.85	-
PB Ratio	3.44	7.49	4.59	11.34	-
P/FCF Ratio	-2.12	-2.30	-2.52	-10.59	-
P/OCF Ratio	-2.12	-2.30	-2.52	-10.59	-
EV/EBITDA Ratio	-1.52	-1.78	-2.88	-7.23	-
EV/EBIT Ratio	-1.35	-1.59	-2.65	-7.23	-
EV/FCF Ratio	-1.81	-2.00	-2.41	-9.14	-
Quick Ratio	4.17	0.71	0.84	2.95	7.87
Current Ratio	4.24	0.72	0.85	2.96	7.87
Return on Equity (ROE)	-102.91%	-201.53%	-171.54%	-147.59%	-
Return on Assets (ROA)	-55.93%	-77.82%	-72.78%	-68.67%	-
Return on Capital (ROIC)	-63.27%	-125.22%	-105.55%	-92.37%	-
Earnings Yield	-50.92%	-55.34%	-36.51%	-11.93%	-
FCF Yield	-47.20%	-43.56%	-39.61%	-9.44%	-
Buyback Yield / Dilution	-33.30%	-34.42%	-15.36%	-354.98%	-
Total Shareholder Return	-33.30%	-34.42%	-15.36%	-354.98%	-

Source: S&P Capital IQ. Standard template. Financial Sources.